MedPath

Lipum AB

Lipum AB logo
🇸🇪Sweden
Ownership
Public
Established
2010-01-01
Employees
1
Market Cap
-
Website
http://www.lipum.se

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts

Phase 1
Completed
Conditions
Rheumatoid Arthritis
Interventions
Biological: Placebo
First Posted Date
2022-10-12
Last Posted Date
2024-12-06
Lead Sponsor
Lipum AB
Target Recruit Count
56
Registration Number
NCT05576012
Locations
🇳🇱

QPS Netherlands B.V., Groningen, Netherlands

🇳🇱

CHDR (Stichting Centre for Human Drug Research), Leiden, Netherlands

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.